Atlas Trials

Survivin Urine mRNA Assay Risk of Bladder Cancer Study

Clinical trial NCT00315653 · COMPLETED

Trial details

NCT number
NCT00315653
Sponsor
Fujirebio Diagnostics, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2005-09-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.